clinical trial · NCT07260708
Clinical Trial of TQB2922 Injection (Subcutaneous Injection) in Patients With Advanced Cancers
Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd.·phase1·recruiting·n = 42
Advanced CancersTQB2922 injection (subcutaneous injection)
brief summary
This is a Phase I clinical study aimed at evaluating the safety and pharmacokinetics of TQB2922 subcutaneous injection in patients with advanced cancers.
started
Dec 16, 2025
primary completion
Dec 1, 2028
completion
Dec 1, 2028
last updated
Apr 21, 2026
official title
A Phase I Clinical Study to Evaluate The Safety and Pharmacokinetics of TQB2922 Injection (Subcutaneous Injection) in Patients With Advanced Cancers
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol